0001669639-24-000001.txt : 20240311 0001669639-24-000001.hdr.sgml : 20240311 20240311162442 ACCESSION NUMBER: 0001669639-24-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanzone Virginia Ruth CENTRAL INDEX KEY: 0001669639 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 24738358 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-03-07 0 0000883984 ICU MEDICAL INC/DE ICUI 0001669639 Sanzone Virginia Ruth 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 VP, General Counsel 0 Common Stock 2024-03-07 4 M 0 1073 0.0 A 5751 D Common Stock 2024-03-07 4 F 0 587 105.39 D 5164 D Common Stock 2024-03-07 4 M 0 6436 0.0 A 11600 D Common Stock 2024-03-07 4 F 0 3529 105.39 D 8071 D Common Stock 2024-03-08 4 S 0 3300 104.5722 D 4771 D Common Stock 2024-03-08 4 M 0 2273 0.0 A 7044 D Common Stock 2024-03-08 4 F 0 1246 104.52 D 5798 D Common Stock 0.0 2024-03-07 4 M 0 1073 0.0 D 2023-03-07 2025-03-07 Common Stock 1073 1073 D Common Stock 2024-03-08 4 A 0 9568 0.0 A Common Stock 9568 9568 D Performance Shares 0.0 2024-03-07 4 M 0 6436 0.0 D 2024-03-07 Common Stock 6436 0 D Performance Shares 0.0 2024-03-08 4 M 0 2273 0.0 D 2023-03-08 2024-03-08 Common Stock 2273 0 D These securities are Restricted Stock Units. These Securities are Performance-based Restricted Stock Units (PRSU). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.54 to $104.84, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. There is neither a purchase price nor an exercise price for the Restricted Stock Units. One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These are restricted stock units that fully vest 3 years from the grant date. There is neither a purchase price nor an exercise price for the PRSUs. These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant. These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. By: Paula Darbyshire, Attorney-in-fact For: Virginia Sanzone 2024-03-11